TY  - JOUR
AU  - Carlsen, K.H.
A2  - Carlsen, K.H.
A2  - Ingjer, F.
A2  - Kirkegaard, H.
A2  - Thyness, B.
DB  - BISp
DP  - BISp
KW  - Ausdauerleistung
KW  - Ausdauersport
KW  - Bronchospasmolytikum
KW  - Inhalation
KW  - Kapazität, aerobe
KW  - Laufleistung
KW  - Leistungsbeeinflussung
KW  - Lungenfunktion
KW  - Pharmakologie
KW  - Sportmedizin
KW  - Sympathikomimetikum
LA  - eng
TI  - The effect of inhaled salbutamol on lung function and endurance performance in healthy well-trained athletes
TT  - Auswirkung von Salbutamol-Inhalation auf Lungenfunktion und Ausdauerleistung von gesunden durchtrainierten Sportlern
PY  - 1997
N2  - The present randomized, double-blind placebo-controlled study aimed at investigating the possible improvement in endurance performance caused by inhaled salmeterol (long-acting beta2-agonist) and salbutamol (short-acting) compared to placebo in 18 healthy well-trained athletes, aged 17-30 years old. Lung function (flow-volume loops) was measured before and after each inhaled study drug and after run to exhaustion. After inhalation of study drug and 10 min warm-up, anaerobic threshold was measured; thereafter maximum oxygen uptake, peak ventilation and running time until exhaustion during a brief graded exercise were measured. No significant differences were found for ventilation, oxygen uptake or heart rate at anaerobic threshold or at maximum performance between placebo and the beta2-agonists. Lung function increased significantly after exercise, but without differences between the beta2-agonists and placebo. Running time till exhaustion was significantly reduced after both the long- und the short-acting beta2-agonist compared to the placebo.   Verf.-Referat
L2  - https://dx.doi.org/10.1111/j.1600-0838.1997.tb00133.x
DO  - 10.1111/j.1600-0838.1997.tb00133.x
SP  - S. 160-165
SN  - 0905-7188
JO  - Scandinavian journal of medicine & science in sports
IS  - 3
VL  - 7
M3  - Gedruckte Ressource
M3  - Elektronische Ressource (online)
ID  - PU199710207721
ER  -